Respinex®

Pulmonology

Respinex®

Registration certificate:

INN:

Glycopyrronium Bromide

Release form:

Inhalation powder hard capsule

Therapeutic Area:

Pulmonology

Pharmacotherapeutic Group:

Other inhalation medications used for the treatment of obstructive respiratory tract diseases, Anticholinergic drugs

Conditions for dispensing:

On prescription

Leaflet:

Packaging:

Indications for Use:

Respinex^® is indicated for the maintenance treatment of bronchial obstruction in patients with chronic obstructive pulmonary disease (COPD).

Included in the List of Essential Medicines.